Source: International Congress 2016 – Pulmonary drug delivery
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Wim Vos (Heist-op-den-Berg, Belgium), Wim Vos, Cedric Van Holsbeke, Jan De Backer, Giovanni Caponetti, Franco Castegini, Marco Sardina, Luca Raiteri, Isabella Salerio, Ioannis Kottakis, Johan Clukers, Wilfried De Backer. Z7200 versus Symbicort® Turbohaler®: A pharmacodynamic evaluation of the acute effects using functional respiratory imaging (FRI). Eur Respir J 2016; 48: Suppl. 60, 968

Member's Comments

No comment yet.

Related content which might interest you: Edry™ an innovative dry powder technology evaluated via functional respiratory imaging (FRI) Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Lung deposition of extrafine vs non-extrafine triple therapies in patients with COPD using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019 Quantitative computed tomography assessment of airway dimensions by combining tiotropium and indacaterol in patients with COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS) Source: International Congress 2014 – Asthma and COPD management Year: 2014 Late Breaking Abstract - Functional respiratory imaging (FRI) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using novel Co-Suspension Delivery Technology (GFF MDI) in COPD Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017 Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Acute radiological abnormalities after bronchial thermoplasty (BT) Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Safety of aclidinium bromide/formoterol fumarate fixed dose combination (FDC) in COPD: Pooled analyses of three phase III studies Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Changes in functional respiratory imaging (FRI) endpoints correlate with changes in patient reported outcomes (PRO) after recovering from acute COPD exacerbation Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Year: 2015 Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (FRI). Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Air-trapping on HRCT as a marker for patient outcome in severe asthmatics treated with azithromycin Source: International Congress 2014 – Different modalities and techniques for lung imaging Year: 2014 Evaluation method of airways for asthma patients using low dose HRCT images Source: International Congress 2016 – Asthma management Year: 2016 Efficacy and safety of VR475 (budesonide suspension delivered by the VR475 Inhalation System) as add-on treatment in patients with severe asthma (CLEARCUT Study) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Pharmacokinetics, safety and tolerability of CHF5993 a triple pMDI in renal impaired patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Abediterol: Efficacy, safety and tolerability of the novel LABA in patients with persistent asthma Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Comparative assessment of umeclidinium/vilanterol (UMEC/VI) combination therapy among symptomatic COPD patients Source: International Congress 2014 – Asthma and COPD management Year: 2014 Integrated analyses of phase II safety data support the safety of glycopyrrolate-formoterol fumarate (GFF) MDI (PT003) and glycopyrrolate (GP) MDI (PT001) in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013